UCB Pharma (Germany)

502 papers and 12.8k indexed citations i.

About

In recent decades, authors affiliated with UCB Pharma (Germany) have published 502 papers, which have received a total of 12.8k indexed citations. Scholars at this organization have produced 118 papers in Rheumatology, 116 papers in Psychiatry and Mental health and 108 papers in Immunology on the topics of Epilepsy research and treatment (98 papers), Pharmacological Effects and Toxicity Studies (96 papers) and Psoriasis: Treatment and Pathogenesis (86 papers). Their work is cited by papers focused on Neurology (2.9k citations), Psychiatry and Mental health (2.5k citations) and Molecular Biology (2.2k citations). Authors at UCB Pharma (Germany) collaborate with scholars in Germany, United States and Belgium and have published in prestigious journals including Nature, The Lancet and Journal of Clinical Oncology. Some of UCB Pharma (Germany)'s most productive authors include Youxin Li, Thomas Kissel, Dagmar Fischer, Barbara Ahlemeyer, Josef Krieglstein, Martin Feelisch, Willi Cawello, Babak Boroojerdi, Bengt Hoepken and Konrad J. Werhahn.

In The Last Decade

Fields of papers published by authors at UCB Pharma (Germany)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with UCB Pharma (Germany) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with UCB Pharma (Germany) at the time of their publication.

Countries citing scholars working at UCB Pharma (Germany)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at UCB Pharma (Germany). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at UCB Pharma (Germany) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites UCB Pharma (Germany) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025